Table 2

Weighted mean daily faecal blood loss by therapy

Treatment/drug
Studies or study arms (n)
Participants (n)
Weighted mean faecal blood loss (ml/day)

Initial blood loss at start of trial
38
950
0.46
Placebo arm of treatment
14
172
0.76
Aspirin (>1,800 mg/day)
29
361
5.01
Aspirin (325 mg/day)
4
64
1.61
Ibuprofen
4
66
2.03
Fenoprofen
4
62
1.86
Piroxicam
6
60
1.89
Naproxen
4
59
1.98
Indomethacin
6
58
1.39
Etodolac
4
39
0.55
Rofecoxib
1
37
0.80
Diflusinal
4
33
1.68
Ketoprofen
3
28
1.42
Meloxicam
1
26
0.85
Etoricoxib
1
21
0.90
Diclofenac
1
21
0.50
Azapropazone
2
20
1.00
Suoprofen
1
20
1.80
Nefopam
1
19
0.60
Tiaprofen
2
17
0.51
Zomepirac
2
16
6.40
Oxindanac
1
16
1.30
Sulindac
2
15
0.75
Lornoxicam
1
15
0.80
Bromfenac
1
12
2.10
Fluproquazone
1
12
2.80
Nabumetone
1
10
1.60
Oxaprozin
1
10
2.30
Isoxicam
1
8
1.00
Ticlotil
1
8
2.10
Tenoxicam
1
6
1.20
Flurbiprofen
1
6
1.30

Note that all low dose aspirin was 325 mg/day.

Moore et al. Arthritis Research & Therapy 2008 10:R7   doi:10.1186/ar2355

Open Data